Elevated getaway with a limited-edition collection of swimwear, accessories, and activities inspired and brought to life by the signature Family Traditions of St. Regis.
SHANGHAI,...
Invests $1 Million To Build A Strategic Team Globally To Accelerate Growth
BANGALORE, India, Aug. 14, 2025 /PRNewswire/ -- Felicity, an AI enabled game-tech company known...
Invests $1 Million To Build A Strategic Team Globally To Accelerate Growth
BANGALORE, India, Aug. 14, 2025 /PRNewswire/ -- Felicity, an AI enabled game-tech company known...
TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three and six months ended June 30, 2025. All dollar amounts set out herein are in thousands of Canadian dollars, unless otherwise stated.
VERO BEACH, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (the “Company”) (NYSE: ORC) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of August 2025. The dividend of $0.12 per share will be paid September 29, 2025 to holders of record of the Company’s common stock on August 29, 2025, with an ex-dividend date of August 29, 2025. The Company plans on announcing its next common stock dividend on September 8, 2025.
First Half Revenue of $45,118Prepaid subscription fees received from customers for our SaaS service were $1.5 Million.
HONG KONG, Aug. 13, 2025 /PRNewswire/ -- FiEE,...
BALLERUP, Denmark, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (Nasdaq: LIQT) ("LiqTech"),a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the second quarter of 2025 for the period ended June 30, 2025.
New partnership set to cement Singapore as a global gaming and esports epicentreSINGAPORE, Aug. 13, 2025 /PRNewswire/ -- Competitive entertainment company BLAST has announced a...
YANTAI, China, Aug. 13, 2025 /PRNewswire/ -- On August 13th, Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met...
Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...
Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...
- Seasoned global leaders have successfully supported 16 landmark nuclear projects across the UAE and China
- Fermi America bringing global "Power Couple" home to...